This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
International Flavors-Neptune Team to Co-Develop CBD Products
by Zacks Equity Research
International Flavors (IFF) focused on developing hemp-derived CBD products for customers in natural health & wellness products.
Newell Stock Rises 33% on Robust Transformational Gains
by Zacks Equity Research
Newell (NWL) progresses well with the Transformation Plan, which is driving its performance and positioning it well for growth.
Inter Parfums (IPAR) Misses on Q3 Earnings, Raises View
by Zacks Equity Research
Inter Parfums (IPAR) Q3 performance benefits from growth in European and U.S.-based operations.
International Flavors' (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for FDVV
The Zacks Analyst Blog Highlights: Dollar General, MarketAxess, Procter & Gamble, Chipotle Mexican and Advanced Micro
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Dollar General, MarketAxess, Procter & Gamble, Chipotle Mexican and Advanced Micro
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.
Clorox (CLX) Beats Q1 Earnings Estimates, Sales Miss (Revised)
by Zacks Equity Research
Clorox (CLX) reports earnings beat in first-quarter fiscal 2020. However, sales miss estimates on higher trade promotional spending, unfavorable mix, and adverse currency rates.
Clorox (CLX) Beats Earnings & Sales Estimates in Q1 (revised)
by Zacks Equity Research
Clorox (CLX) reports first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Clorox (CLX) Falls Short Of Earnings & Sales Estimates in Q1
by Zacks Equity Research
Clorox (CLX) reports dismal first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Third Time Rate Cut Works Wonders for Wall Street: 5 Winners
by Tirthankar Chakraborty
Historically, the S&P 500 has jumped 10% in the six months and 20% in the 12 months following a trio of interest rate cuts of 25 basis points each.
The Zacks Analyst Blog Highlights: Procter & Gamble, Intel, Adobe, Walmart and Texas Instruments
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Intel, Adobe, Walmart and Texas Instruments
Procter & Gamble, Hasbro, Copart, Lululemon and KeySight Technologies highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Procter & Gamble, Hasbro, Copart, Lululemon and KeySight Technologies highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Procter & Gamble (PG)
by Madeleine Johnson
This consumer staples giant showed that it's still capable of impressive sales and EPS growth.
Top Analyst Reports for Procter & Gamble, Intel & Adobe
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Intel Corporation (INTC) and Adobe Inc. (ADBE).
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKF
Solid PG Earnings to Further Boost Staples ETFs
by Sanghamitra Saha
Procter & Gamble beats overall and should boost these consumer staples ETFs.
Company News For Oct 23, 2019
by Zacks Equity Research
Companies In The News Are: PG,UTX,NEE,CNC
Procter & Gamble (PG) Stock Rises on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble's (PG) sales and earnings beat estimates in Q1 on organic sales growth in all segments, margin expansion and cash productivity gains. It raises view for fiscal 2020.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
The Zacks Analyst Blog Highlights: Procter & Gamble, United Technologies, Boeing, Merck & Co. and Apple
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, United Technologies, Boeing, Merck & Co. and Apple
Earnings Surprise May Lift Stocks: Buy These Growth ETFs
by Sweta Killa
Market participants are betting on the record-high U.S. indices as about 120 S&P 500 companies are scheduled to release their results this week.
Should You Buy Procter & Gamble (PG) Ahead of Earnings?
by Zacks Equity Research
Procter & Gamble (PG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Dow Stocks Poised to Beat on Earnings This Month
by Nalak Das
Despite severe market volatility, the Dow is still in positive territory with a gain of 15.9% year to date. This is an excellent performance after a disappointing 2018.
Procter & Gamble (PG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $117.56 in the latest trading session, marking a +0.31% move from the prior day.